Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/23940
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKoshy, Anoop N-
dc.contributor.authorFarouque, Omar-
dc.contributor.authorGow, Paul J-
dc.date2020-07-22-
dc.date.accessioned2020-08-03T06:35:52Z-
dc.date.available2020-08-03T06:35:52Z-
dc.date.issued2020-10-
dc.identifier.citationEuropean journal of internal medicine 2020; 80: 104-
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/23940-
dc.language.isoeng-
dc.titleTargeted pharmacotherapy for cardiovascular risk reduction in patients with diabetes undergoing liver transplantation.-
dc.typeJournal Article-
dc.identifier.journaltitleEuropean journal of internal medicine-
dc.identifier.affiliationVictorian Liver Transplant Unit, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Cardiology, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationThe University of Melbourne, Parkville, Victoria, Australiaen
dc.identifier.doi10.1016/j.ejim.2020.07.018-
dc.identifier.orcid0000-0002-8741-8631en
dc.identifier.orcid0000-0001-6505-7233en
dc.identifier.pubmedid32711921-
dc.type.austinLetter-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

16
checked on May 7, 2021

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.